January 8, 2020
NEW YORK -- Schrödinger and Bayer (BAYN: DE) today announced a five-year technology alliance to develop a comprehensive de novo design solution with the objective to accelerate the discovery of innovative high-quality drugs. The technology is expected to be capable of enumerating, screening, and scoring billions of synthetically feasible, virtual compounds supporting the identification and optimization of [...]
January 8, 2020
Certara’s Simcyp® Simulator’s MechDermA™ model provided safety label claim and pediatric dosing information without the need for testing in clinical patients for a topical drug product. Certara®, the global model-informed drug development and decision support leader, today announced that its Simcyp® Population-based Simulator was used to support Galderma’s successful U.S. Food and Drug Administration (FDA) new [...]
January 8, 2020
BC Platforms, a world leader in genomic data management and analytics, today announced that it has formed a partnership with Dante Labs, a global genetic testing and data analysis company specialized in whole genome sequencing and interpretation intended both for Direct To Consumers and larger scale Life Science industry projects. With the steps taken, Dante [...]
Single Cell Genome Sequencing Company BioSkryb Raises $11.5M in Seed Funding Round
January 8, 2020
DURHAM – BioSkryb, a developer of genomic amplification technologies that deliver higher coverage and fidelity for gene sequencing, today announced it raised $11.5 million in new funding. This Seed round was led by venture capital firm Anzu Partners and included the law firm Wilson Sonsini Goodrich & Rosati. The funding will accelerate BioSkryb’s product roadmap [...]
Gemini Bio to Distribute Celartia Products in the United States
January 8, 2020
WEST SACRAMENTO, CA, and COLUMBUS, OH – Gemini Bioproducts, LLC (“Gemini”), a leading supplier of cell culture solutions and a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), a New York-based healthcare private equity firm, today announced a distribution agreement with Celartia, Inc. Effective immediately, customers can now purchase Celartia’s line of closed, single-use cell [...]
January 8, 2020
BC Platforms, a world leader in genomic data management and analytics, today announced that it has formed a partnership with Dante Labs, a global genetic testing and data analysis company specialized in whole genome sequencing and interpretation intended both for Direct To Consumers and larger scale Life Science industry projects. With the steps taken, Dante [...]
Single Cell Genome Sequencing Company BioSkryb Raises $11.5M in Seed Funding Round
January 8, 2020
DURHAM – BioSkryb, a developer of genomic amplification technologies that deliver higher coverage and fidelity for gene sequencing, today announced it raised $11.5 million in new funding. This Seed round was led by venture capital firm Anzu Partners and included the law firm Wilson Sonsini Goodrich & Rosati. The funding will accelerate BioSkryb’s product roadmap [...]
January 7, 2020
Quality Immune Checkpoint Proteins Release by Beta Lifescience for the Month of January 2020 FIREFILED, N.J. -- Beta Lifescience, a world leading biotech company based in NJ, USA, announces that scientists in the field of cancer immunotherapy, immune checkpoint, targeted therapy, etc. now have access to the quality immune checkpoint protein products through the company's newly launched website. Immune checkpoints refer to [...]
January 7, 2020
Track the health of cell cultures without removing them from the incubator The OLYMPUS Provi CM20 incubation monitoring system* provides quantitative data about the health of cell cultures while they are in the incubator. The system periodically scans the cultures, counts the number of cells, determines confluency and wirelessly communicates the data to a tablet [...]
Shoreline Biome announces international distribution partnership in Japan
January 7, 2020
FARMINGTON, Conn.— Shoreline Biome, a microbiome research company based here that develops tools for characterizing microbiome populations down to the strain level, has announced a distribution partnership with TOMY Digital Biology Co., Ltd., a leading Japanese biotech organization. TOMY provides high-quality instruments and services to industry segments including biotechnology, biological engineering, medical science, and food [...]
